FDA Approves First Treatment for Adult Onset Still’s Disease
The U.S. Food and Drug Administration approved Ilaris (canakinumab) injection for the treatment of Active Still’s disease, including Adult-Onset Still’s Disease.
About PR Newswire
This author has yet to write their bio.Meanwhile lets just say that we are proud PR Newswire contributed a whooping 970 entries.
Entries by PR Newswire
FDA approves Lyumjev, Lilly’s new rapid-acting insulin
The U.S. Food and Drug Administration approved Eli Lilly’s Lyumjev (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), a new rapid-acting insulin indicated to improve glycemic control in adults with type 1 and type 2 diabetes.
Intravacc Partners to Develop Intranasal COVID-19 Vaccine
Intravacc is partnering with Wageningen Bioveterinary Research and Utrecht University to develop an intranasal COVID-19 vaccine.
Taltz receives U.S. FDA approval for nr-axSpA
The U.S. Food and Drug Administration approved a supplemental Biologics License Application for Eli Lilly and Company’s Taltz (ixekizumab) injection 80 mg/mL for the treatment of active non-radiographic axial spondyloarthritis (nr-axSpA) in patients with objective signs of inflammation.
Outcome Health Announces OH Virtual Waiting Room
Outcome Health announced the OH Virtual Waiting Room, ushering the Point of Care sector into telemedicine with an empathetic, unique patient experience whenever and wherever patients are meeting with their physicians.
U.S. FDA Approves Evofem Biosciences’ Phexxi
The U.S. Food and Drug Administration approved Evofem Biosciences Inc.’s Phexxi (lactic acid, citric acid and potassium bitartrate) vaginal gel for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception.
Havas Health & You Launches Havas Mango
Havas Health & You (HH&Y) announced the launch of Havas Mango, a Miami-based collective aiming to reimagine wellness and build experiences that help people live their best lives.
Thermo Fisher Scientific Response to COVID-19 Expands to Include New Serology Test
Thermo Fisher Scientific Inc. expanded the company’s response to the COVID-19 pandemic by developing a total antibodies test in collaboration with WuXi Diagnostics and Mayo Clinic.
iSpecimen to supply CDC with blood samples to help advance understanding of COVID-19 immunity
iSpecimen will supply the U.S. Centers for Disease Control and Prevention (CDC) with serum samples from subjects who have previously tested positive for SARS-CoV-2, the virus that causes COVID-19.
EVERSANA Appoints Kelly Baker to Chief Financial Officer
EVERSANA, a leading independent provider of global commercial services to the life sciences industry, announced the appointment of Kelly Baker to Chief Financial Officer (CFO).